Showing results (31-40 of 352) with videos related to

Sort By:
Pageof 36
Current Medical Research and Opinion|February 20, 2008
Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysisMei Sheng Duh, Jennifer Reynolds Weiner, Patrick Lefebvre, et al.
The Oncologist|June 22, 2005
Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curveMei Sheng Duh, Patrick Lefebvre, John Fastenau, et al.
Crohn'S & Colitis 360|September 6, 2023
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United StatesMaryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, et al.
Journal of Health Economics and Outcomes Research|March 2, 2022
Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United StatesBruno Emond, Carmine Rossi, Rachel Rogers, et al.
American Health & Drug Benefits|July 10, 2015
Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate CancerLorie A Ellis, Marie-Hélène Lafeuille, Laurence Gozalo, et al.
Clinical Therapeutics|August 1, 2021
Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective StudyNilanjan Ghosh, Bruno Emond, Marie-Hélène Lafeuille, et al.
American Journal of Medical Genetics. Part A|December 15, 2016
Out-of-pocket medical costs and third-party healthcare costs for children with Down syndromeAndrew Kageleiry, David Samuelson, Mei Sheng Duh, et al.
Menopause (New York, N.Y.)|October 26, 2018
Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapyFrançois Laliberté, Katherine Dea, Mei Sheng Duh, et al.
Menopause (New York, N.Y.)|July 22, 2011
Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapyFrançois Laliberté, Katherine Dea, Mei Sheng Duh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 26, 2012
Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthmaMarie-Hélène Lafeuille, Jason Dean, Jie Zhang, et al.
Pageof 36